Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hoth Therapeutics Inc (HOTH)

Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hoth Therapeutics Inc 1177 Avenue of the Americas 5th Floor Suite 5066 New York NY 10036 USA

https://hoththerapeutics.com Employees: 3 P: 646-756-2997

Sector:

Medical

Description:

Hoth Therapeutics Inc. is a development stage biopharmaceutical company. It focused on therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. The company's BioLexa(TM) Platform is a proprietary, patented drug compound platform. Hoth Therapeutics Inc. is based in New York, United States.

Key Statistics

Overview:

Market Capitalization, $K 18,617
Enterprise Value, $K 11,577
Shares Outstanding, K 15,514
Annual Sales, $ 0 K
Annual Net Income, $ -8,190 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,110 K
EBIT, $ -12,140 K
EBITDA, $ -12,140 K
60-Month Beta 0.64
% of Insider Shareholders 6.92%
% of Institutional Shareholders 7.08%
Float, K 14,440
% Float 93.08%
Short Volume Ratio 0.48

Growth:

1-Year Return 43.97%
3-Year Return -62.96%
5-Year Return -97.26%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 93.90%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 11/12/25
Next Earnings Date 11/11/25
Earnings Per Share ttm -1.06
EPS Growth vs. Prev Qtr -76.47%
EPS Growth vs. Prev Year 3.23%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/26/22

HOTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -133.69%
Return-on-Assets % -123.43%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.92
Book Value/Share 0.62
Interest Coverage -0.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar